Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |